Abstract
Oestrogen receptor (ER) is used routinely to predict endocrine responsiveness in patients with breast cancer. A second ER, ERβ has been described but its significance remains undefined; most studies have described mRNA levels rather than protein expression. Here, we demonstrate for the first time, immunohistochemical detection of ERβ in archival breast tumours. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Allred DC, Harvey MJ, Berardo M and Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 2: 155–168
Dotzlaw H, Leygue E, Watson PH and Murphy LC (1999) Estrogen receptor β messenger RNA expression in human breast tumour biopsies: Relationship to steroid receptor status and regulation by progestins. Cancer Res 59: 529–532
Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P and Chambon P (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v- erb -A. Nature 320: 134–139
Harvey JM, Clark GM, Osborne CK and Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474–1481
Jarvinen TAH, Pelto-Huikko M, Holli K and Isola J (2000) Estrogen receptor β is co-expressed with ERα and PR and associated with nodal status, grade and proliferation in breast cancer. Am J Pathol 156: 29–35
Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustaffson JA (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925–5930
Leygue E, Dotslaw H, Watson PH and Murphy LC (1998) Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis. Cancer Res 58: 3197–3201
Mosselman S, Polman J and Dijkema R (1996) ER-β: identification and characterisation of a novel human estrogen receptor. FEBS Lett 392: 49–53
Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustaffson J-A, Kushner PJ and Scanlan TS (1997) Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science 277: 1508–1510
Speirs V, Malone C, Walton DS, Kerin MJ and Atkin SL (1999a) Increased expression of estrogen receptor β mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 59: 5421–5424
Speirs V, Parkes AT, Kerin MJ, Walton DS, Carleton PJ, Fox JN and Atkin SL (1999b) Co-expression of estrogen receptor-α and -β: Poor prognostic factors in human breast cancer?. Cancer Res 59: 525–528
Speirs V, Adams IP, Walton DS and Atkin SL (2000) Identification of wild type and exon 5 deletion variants of estrogen receptor β in normal human mammary gland. J Clin Endo Metab 85: 1601–1605
Taylor AH and Al-Azzawi F (2000) Immunolocalisation of oestrogen receptor beta in human tissues. J Molec Endocrinol 24: 145–155
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Skliris, G., Carder, P., Lansdown, M. et al. Immunohistochemical detection of ERβ in breast cancer: towards more detailed receptor profiling?. Br J Cancer 84, 1095–1098 (2001). https://doi.org/10.1054/bjoc.2001.1721
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1721
Keywords
This article is cited by
-
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
BMC Cancer (2014)
-
Steroid hormone receptor expression in breast cancer stroma
Breast Cancer Research and Treatment (2014)
-
Estrogen receptor status of breast stromal cells
Breast Cancer Research and Treatment (2014)
-
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
BMC Cancer (2013)
-
Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancer
Medical Oncology (2013)